Heparin Cause Hyperkalemia Jun 2026

Not all patients receiving heparin develop hyperkalemia. Predisposing factors significantly increase the risk:

While standard prophylactic doses primarily work via receptor blockade, therapeutic (high) doses of heparin have been shown to inhibit the enzymatic pathway (CYP11B1 and CYP11B2) required for aldosterone synthesis in the adrenal cortex. This reduces the overall circulating levels of the hormone.

Management depends on the severity of hyperkalemia and the clinical need for anticoagulation. heparin cause hyperkalemia

: Heparin may also interfere with late-stage enzymatic steps (specifically 18-hydroxylase) required for aldosterone synthesis. Lest We Forget: Heparin-Induced Hyperkalemia

Aldosterone, secreted by the adrenal cortex, is the body’s primary regulator of sodium and potassium balance. It acts on the distal tubules and collecting ducts of the kidney to promote sodium reabsorption and potassium excretion. Not all patients receiving heparin develop hyperkalemia

Heparin causes hyperkalemia primarily by impairing renal potassium excretion. The key mechanism is heparin-induced suppression of aldosterone synthesis. Aldosterone, a mineralocorticoid hormone produced by the adrenal zona glomerulosa, enhances potassium secretion in the distal nephron of the kidney. Heparin and its derivatives (including unfractionated heparin and low-molecular-weight heparin) inhibit aldosterone production through several pathways:

The mechanism of hyperkalemia centers on . Management depends on the severity of hyperkalemia and

Certain patients may be at higher risk for developing heparin-induced hyperkalemia, including:

As hospital protocols increasingly emphasize VTE prophylaxis, clinicians must maintain a high index of suspicion. Checking a baseline potassium and monitoring it 24 to 48 hours after initiating heparin in high-risk patients is a simple intervention that can prevent a lethal complication.